| In order to better serve registrants, the Patient Notification System was created by the Plasma Protein Therapeutics Association (PPTA), its members, and other producers of plasma derived recombinant
analog therapies (hereafter referred to as the 'Plasma Therapeutics Industry'). The PLASMA THERAPEUTICS INDUSTRY has retained the services of Stericycle, Inc.,
an independent notification service company, to provide prompt notification to registrants in necessary situations. The PLASMA THERAPEUTICS INDUSTRY hereby pledges to respect the confidential nature of the information
supplied to Stericycle, Inc. by registrants and further pledges not to inquire about, encourage divulgence of, or request such information. Specifically, the PLASMA THERAPEUTICS INDUSTRY has agreed with Stericycle, Inc. that it shall
not have access or claim to any such registrant information. Any information that is submitted via this web site is secured using SSL encryption. |
| Prior to registering, it is important for you to understand that it is YOUR responsibility to maintain your information. Provided your information is correct, you will be notified by Stericycle, Inc..
Stericycle, Inc. can not notify you if your information is incorrect. Your mailing address is required. Regardless of the results of your primary method of notification, you will receive a followup first class letter.
If your primary method of notification fails, Stericycle, Inc. will also send you a change form. You MUST return this change form with the corrected information to ensure prompt delivery via your preferred method of notification.
If there are three failed attempts to contact you, your registration will be deactivated. Changing any of your registration information will reset the number fails to zero.